Guardant Health
GH
#1557
Rank
NZ$23.00 B
Marketcap
NZ$177.10
Share price
-0.57%
Change (1 day)
189.22%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$2.20 Billion

According to Guardant Health 's latest financial reports the company's total assets are NZ$2.20 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$2.63 B-6.75%
2023-12-31NZ$2.82 B11.4%
2022-12-31NZ$2.53 B-21.43%
2021-12-31NZ$3.22 B2.51%
2020-12-31NZ$3.14 B120.3%
2019-12-31NZ$1.42 B63.2%
2018-12-31NZ$0.87 B81.35%
2017-12-31NZ$0.48 B186.95%
2016-12-31NZ$0.16 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Natera
NTRA
NZ$3.14 B 42.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
NZ$5.83 B 164.58%๐Ÿ‡บ๐Ÿ‡ธ USA